A critical advance in cancer study is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential tumor protector protein is frequently lost in various forms of tumors, resulting uncontrolled https://mysterybookmarks.com/story21883427/vhh-fragments-reactivate-the-p53-protein-a-potential-approach-for-cancer-management